The Global Contrast Media/Contrast Agents Market is Projected to Reach USD 6.0 Billion by 2024, Growing at a CAGR of 3.8% - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Contrast Media/Contrast Agent Market by Type (Iodinated, Gadolinium, Barium, and Microbubble), Procedure (X-Ray/CT, MRI, and Ultrasound), Application (Radiology, Interventional Radiology, and Interventional Cardiology), Region - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

The global contrast media market is expected to reach USD 6,047.3 million by 2024 from an estimated USD 5,024.1 million in 2019, at a CAGR of 3.8% during the forecast period. Growth in the market can primarily be attributed to the increasing prevalence of cancer and CVDs, approvals of contrast agents, and the increasing demand for early diagnosis as well as the rising volume of CT and MRI examinations. On the other hand, factors such as side-effects and allergic reactions associated with contrast agents are expected to limit market growth to a certain extent.Geographically, North America accounted for the largest share of 37.9% of the contrast media market. This market segment is expected to grow at a CAGR of 3.7% from 2019 to 2024. However, the market in theAsia Pacific is expected to grow at the highest CAGR of 4.1% during the forecast period. This is mainly due to the growing R&D investments and favorable demographic scenario in China, the growing aging population and cancer incidence in Japan, growing investments in the Indian radiology market, and the focus of market players on these countries.

This report studies the Contrast Media/Contrast Agents market based on product, application, modality, indication, route of administration and region. The report also studies the different factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Contrast Media Market Overview

4.2 European Contrast Media Market, By Modality (2019)

4.3 Contrast Media Market Share, By Modality, 2019 vs. 2024

4.4 Contrast Media Market Share, By Route of Administration, 2019 vs. 2024

4.5 Contrast Media Market Share, By Indication, 2019 vs. 2024

4.6 Contrast Media Market Share, By Application, 2019 vs. 2024

4.7 Contrast Media Market Share, By Type, 2019 vs. 2024

4.8 Geographic Snapshot: Contrast Media Market

5 Market Overview

5.1 Introduction

5.2 Market Dynamics

5.2.1 Drivers

5.2.1.1 Increasing Prevalence of Cancer and CVDs

5.2.1.2 Approvals of Contrast Agents

5.2.1.3 Increasing Demand for Early Diagnosis and Rising Volume of CT and MRI Examinations

5.2.2 Restraints

5.2.2.1 Side-Effects and Allergic Reactions Associated With Contrast Agents

5.2.3 Opportunities

5.2.3.1 Generic Contrast Media

5.2.3.2 Increasing Research

5.2.4 Challenges

5.2.4.1 Technological Advancements in Imaging Solutions

5.2.4.2 Restriction and Withdrawal of Linear Gadolinium-Based Contrast Agents

6 Contrast Media/Contrast Agents Market, By Type

6.1 Introduction

6.2 Iodinated Contrast Media

6.3 Gadolinium-Based Contrast Media

6.4 Microbubble Contrast Media

6.5 Barium-Based Contrast Media

7 Contrast Media/Contrast Agents Market, By Modality

7.1 Introduction

7.2 X-Ray/Ct

7.3 Magnetic Resonance Imaging

7.4 Ultrasound

8 Contrast Media/Contrast Agents Market, By Indication

8.1 Introduction

8.2 Cardiovascular Diseases

8.3 Cancer

8.4 Gastrointestinal Disorders

8.5 Musculoskeletal Disorders

8.6 Neurological Disorders

8.7 Nephrological Disorders

9 Contrast Media/Contrast Agents Market, By Route of Administration

9.1 Introduction

9.2 Intravascular Route

9.3 Oral Route

9.4 Rectal Route

9.5 Other Routes of Administration

10 Contrast Media/Contrast Agents Market, By Application

10.1 Introduction

10.2 Radiology

10.3 Interventional Radiology

10.4 Interventional Cardiology

11 Contrast Media/Contrast Agents Market, By Region

12 Competitive Landscape

12.1 Introduction

12.2 Market Share Analysis

12.3 Right-To-Win

12.4 Competitive Leadership Mapping

12.5 Competitive Scenario

13 Company Profiles

14 Appendix

Companies Mentioned

• Bayer AG
• Bracco Imaging S.P.A
• CT Contrast Agents: Product Comparison
• Daiichi Sankyo
• GE Healthcare
• Guerbet Group
• Imax Diagnostic Imaging Limited
• Interpharma Praha A.S.
• J.B. Chemicals and Pharmaceuticals Ltd.
• Jodas Expoim
• Kiran X-Ray
• Lantheus Medical Imaging, Inc.
• M. Biotech Limited
• Magnus Health
• MRI Contrast Agents: Product Comparison
• Nano Therapeutics Pvt. Ltd.
• Sanochemia
• Spago Nanomedical AB
• Subhra Pharma Pvt. Ltd.
• Taejoon Pharm
• Ultrasound Contrast Agents: Product Comparison
• Unijules Life Sciences
• Yangtze River Pharmaceutical Group (YRPG)

For more information about this report visit https://www.researchandmarkets.com/r/ckr7m3

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.